Whole-body MRI for the Detection of Metastasis

Withdrawn

• Conditions: Breast Cancer; Metastases

• Registration Number: NCT02183597
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-05-16
• Study First Submitted QC: 2014-07-02
• Study First Posted: 2014-07-08
• Study Start: 2016-03
• Status Verified: 2016-08
• Last Update Submitted: 2016-08-08
• Last Update Posted: 2016-08-10
• Primary Completion: 2018-03
• Study Completion: 2018-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• Cancer patient

Exclusion Criteria

• Poor general condition
• Pacemaker or other MRI contraindications

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of metastasis in skeleton	Baseline and after 6 months	Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease